Clinical Trial Update: Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

View source ↗

Summary

The clinical trial NCT00721097 assessing predictive factors for exacerbation outcomes in severe refractory asthmatics has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Nantes University Hospital | Conditions: Asthma, Chronic Inflammatory Diseases | Status: TERMINATED